Arthur F. Golden - 23 Oct 2025 Form 4 Insider Report for Turn Therapeutics Inc. (TTRX)

Role
Director
Signature
/s/ Zuraiz Chaudhary, attorney-in-fact for Arthur Golden
Issuer symbol
TTRX
Transactions as of
23 Oct 2025
Net transactions value
+$100,000
Form type
4
Filing time
23 Oct 2025, 21:01:34 UTC
Previous filing
10 Oct 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GOLDEN ARTHUR F Director C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE /s/ Zuraiz Chaudhary, attorney-in-fact for Arthur Golden 23 Oct 2025 0001023260

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTRX Common Stock Purchase $100,000 +20,202 +202% $4.95 30,202 23 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain of the securities reported in Column 5 of Table I are restricted stock units ("RSUs") granted under the Issuer's 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and the reporting person's continuous service through the vesting date.